Navigation Links
ViroPharma Announces Positive CHMP Opinion for Buccolam® (Midazolam, Oromucosal Solution) in the European Union
Date:6/24/2011

thorization Applications (MAAs) for medicines for human use. Their positive opinion forms the scientific basis for the European Commission to issue a binding decision for an MAA or a PUMA, a centralized marketing authorization which is valid throughout all the Member States of the European Union (EU) as well as in the European Economic Area (EEA), namely Norway, Iceland and Liechtenstein. The anticipated timeframe for the European Commission decision is by the fourth quarter of 2011.  A summary of the CHMP opinion will be available here: http://tinyurl.com/2am4ubc.  Please select "B" to access the Buccolam summary opinion.  

"This positive CHMP opinion - the first for a product seeking centralized authorization through a PUMA - is a great step towards the European marketing authorization for Buccolam, a product that addresses significant unmet need for families and caregivers – namely the quick and effective termination of prolonged, acute convulsive seizures in children and adolescents," commented Thierry Darcis, M.D., ViroPharma's vice president, general manager, Europe.  "We will work closely with physicians across Europe on improving the seizure treatment paradigm, and bringing this much-needed emergency medication to market as soon as possible this year."

A Pediatric Use Marketing Authorization (PUMA) is a new type of centralized marketing authorization procedure for medicines that are developed specifically for children and may already be authorized for other indications or routes of administration in adults but are not patented. These medicines benefit from 10 years of market protection as an incentive.  In August 2010, the EMA's Pediatric Committee (PDCO) confirmed that the required Pediatric Investigation Plan (PIP) for Buccolam had been fully completed.  

About Buccolam® (Midazolam, Oromucosal Solution)

Buccolam is oral midazolam prov
'/>"/>

SOURCE ViroPharma Incorporated
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. ViroPharmas Cinryze® (C1 Inhibitor [Human]) Granted European Marketing Authorization for Hereditary Angioedema (HAE)
2. ViroPharma to Participate in the Jefferies 2011 Global Healthcare Conference
3. ViroPharma Launches Swell, an Original Documentary Chronicling the Lives of People Living with Hereditary Angioedema
4. ViroPharma Initiates Phase 2 Study of VP 20621 for Prevention of Recurrence of Clostridium difficile Infection (CDI)
5. Halozyme Therapeutics and ViroPharma Announce $83 Million Global Licensing Agreement to Develop Subcutaneous Cinryze® (C1 esterase inhibitor [human])
6. ViroPharma and Halozyme Announce Collaboration for Combination of Recombinant Human Hyaluronidase Enzyme (rHuPH20) Technology with C1 Esterase Inhibitor
7. ViroPharma to Participate In Three May Healthcare Investor Conferences
8. ViroPharma to Release 2011 First Quarter Financial Results On April 28, 2011
9. ViroPharma Initiates Phase 2 Study of C1 Esterase Inhibitor [Human] for Treatment of Antibody-Mediated Rejection (AMR)
10. ViroPharma Launches HAE and Me, A New Online Community to Unite People Living With Hereditary Angioedema
11. ViroPharma Announces Positive CHMP Opinion for Cinryze® (C1 Inhibitor [Human]) in European Union
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... , Jan. 23, 2015  Lixte Biotechnology Holdings, Inc. (OTCQB: LIXT), ... I trial of Lixte,s lead compound, LB‑100, is being conducted, ... John S. Kovach , M.D., the founder and President ... be completed at a single site. Accrual of patients, however, ...
(Date:1/23/2015)... , Jan. 23, 2015   Leatt Corporation  (OTCQB: LEAT), ... equipment for all forms of sports, including extreme motor ... brace, announced today that the UISP Lega Motociclismo Lombardia, ... all riders to wear a neck brace during its ...
(Date:1/23/2015)... 23, 2015  Mallinckrodt plc (NYSE: MNK ) ... a share repurchase program. The open-ended authorization permits the ... plc ordinary shares. "Funding additional initiatives ... as we continue to pursue a range of focused ...
Breaking Medicine Technology:Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 3Leatt Announces Neck Braces Now Required For Motocross/Minicross Racing In Italy 2Leatt Announces Neck Braces Now Required For Motocross/Minicross Racing In Italy 3Mallinckrodt plc Announces Share Repurchase Program 2Mallinckrodt plc Announces Share Repurchase Program 3Mallinckrodt plc Announces Share Repurchase Program 4
... 2011 /PRNewswire-Asia/ -- Chindex International, Inc. (NASDAQ: ... care services in China through the operations of United Family ... ambulatory clinics, today announced financial results for the three month ... Quarter 2011 Financial Highlights Revenue from ...
... MOUNTAIN VIEW, Calif., May 9, 2011 Alexza Pharmaceuticals, ... results for the fiscal quarter ended March 31, 2011, ... the quarters ended March 31, 2011 and 2010, as ... the United States, was $8.4 million and $13.4 million, ...
Cached Medicine Technology:Chindex International, Inc. Reports First Quarter 2011 Financial Results 2Chindex International, Inc. Reports First Quarter 2011 Financial Results 3Chindex International, Inc. Reports First Quarter 2011 Financial Results 4Chindex International, Inc. Reports First Quarter 2011 Financial Results 5Chindex International, Inc. Reports First Quarter 2011 Financial Results 6Chindex International, Inc. Reports First Quarter 2011 Financial Results 7Chindex International, Inc. Reports First Quarter 2011 Financial Results 8Chindex International, Inc. Reports First Quarter 2011 Financial Results 9Chindex International, Inc. Reports First Quarter 2011 Financial Results 10Alexza Reports 2011 First Quarter Financial Results and Provides Business Update 2Alexza Reports 2011 First Quarter Financial Results and Provides Business Update 3Alexza Reports 2011 First Quarter Financial Results and Provides Business Update 4Alexza Reports 2011 First Quarter Financial Results and Provides Business Update 5Alexza Reports 2011 First Quarter Financial Results and Provides Business Update 6Alexza Reports 2011 First Quarter Financial Results and Provides Business Update 7Alexza Reports 2011 First Quarter Financial Results and Provides Business Update 8Alexza Reports 2011 First Quarter Financial Results and Provides Business Update 9
(Date:1/22/2015)... Houston, TX (PRWEB) January 22, 2015 The ... Pro Bodybuilder Ben Pakulski to increase lean muscle by up ... This has caught the attention of HealthyandFitZone.com’s Stan Stevenson, prompting ... shows that it is a step-by-step, scientific diet formula that ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 Blue Cross and ... Minnesotans who exemplify what it means to “Live Fearless.” ... for people to share their stories about how they or ... simply inspired others by living in the moment. By telling ...
(Date:1/22/2015)... 22, 2015 The federal court overseeing thousands ... District Court, Southern District of West Virginia has upheld a ... proceeding’s first bellwether trial. In an Order dated January 21st, ... after finding that C.R. Bard had not proven a miscarriage ...
(Date:1/22/2015)... Dallas, TX (PRWEB) January 22, 2015 ... the issue of experience and person-centeredness in the long-term ... moving towards action across the continuum. The paper, “The ... the Continuum,” engages perspectives and practices of the patient, ...
(Date:1/22/2015)... Autocarinsurancebest.com has released a new blog post explaining the main ... , Auto insurance quotes help many drivers find the ... to call an agent or visit an agency for price ... website: http://autocarinsurancebest.com/ . , Every business who relies heavily ...
Breaking Medicine News(10 mins):Health News:The Incredible Bulk: Review Examining Ben Pakulski’s Brand New Bulking Muscle Building Diet Program Released 2Health News:Blue Cross and Blue Shield of Minnesota to Showcase “Faces of Fearless” 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 3Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 4Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 2Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 3Health News:Commercial Auto Insurance Provides Several Important Features! 2
... developed a new method for producing proteins critical to ... Zhihao Zhuang, UD assistant professor of chemistry and biochemistry, ... more ubiquitylated proteins than current approaches. Such proteins may ... cancer cells gain resistance to cancer drugs. The ...
... ... user-based community unifying people through their interest in holistic lifestyle principles. ... self discovery. Holistic Guidance enables holistic seekers and practitioners to easily ... one easy, accessible place. To sign up for the HG Community ...
... , ... doors to more dental care , ... (PRWEB) April 1, 2010 -- With the passage of the Patient Protection and Affordable ... needed oral health care. , , ,“We applaud the president and Congress for addressing ...
... ... and with Earth Day just around the corner, Garden of Eve presents a perfect opportunity ... Day offer. , , ... (PRWEB) April 1, 2010 -- Garden of Eve is proud to honor Earth Day 2010 ...
... A study in the April 1 issue of the journal ... was associated with a reduced rate of insomnia and improved ... community. Results of regression analyses indicate that increased ... asleep, higher sleep efficiency and improved sleep quality. Stability ...
... in <A HREF=",http://chinese.eurekalert.org/zh/emb_releases/2010-04/aaoo-amb032510.php,">Chinese . Alexandria, ... thin needles are used to stimulate specific points ... may be an effective treatment option for patients ... (PVOD), according to new research in the April ...
Cached Medicine News:Health News:UD team develops new method for producing proteins critical to medical research 2Health News:Holistic Platform Brings Seeker and Practitioner Communities Together 2Health News:Holistic Platform Brings Seeker and Practitioner Communities Together 3Health News:Health Care Reform Law Could Improve Children's Oral Health, states Delta Dental Plans Association 2Health News:Honoring Earth Day 2010; Garden of Eve Skin Care Showcases Green Goddess Offering 2Health News:Honoring Earth Day 2010; Garden of Eve Skin Care Showcases Green Goddess Offering 3Health News:Maintaining regular daily routines is associated with better sleep quality in older adults 2Health News:Acupuncture may be an effective treatment for post-viral infection loss of smell 2
... extends the ability of interventional cardiologists ... artery disease, and provides non-interventional cardiologists ... the treatment of patients who have ... therapy provides a noninvasive, atraumatic treatment ...
... The dual lumen titanium ... 1.2 mm inner diameter ... oval lumen catheters offer ... maintaining maximum catheter strength. ...
The mid-sized polysulfone is about 3/4 the diameter and half the weight of the standard model. The silicone catheter has an I.D. of 0.9 mm....
... polysulfone port may be ordered ... catheter. The silicone catheter is ... of 0.9, 1.0, 1.4, 1.6 ... available with an inner diameter ...
Medicine Products: